Meeting to be held in Boston on March 3 hosted by Piper Sandler.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRNA:
- Verona Pharma price target raised to $76 from $57 at Truist
- Verona Pharma price target raised to $83 from $68 at Roth MKM
- Verona Pharma’s Strong Market Position and Growth Potential Drive Buy Rating
- Positive Outlook on Verona Pharma’s Ohtuvayre: Strong Sales, Strategic Positioning, and Growth Potential
- Verona Pharma price target raised to $93 from $74 at Wells Fargo